82822:HK:HK-CSOP FTSE China A50 (CNY)

ETF | Others |

Last Closing

USD 12.14

Change

0.00 (0.00)%

Market Cap

USD 9.12B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

-0.18 (-0.93%)

USD 140.29B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

-0.48 (-0.68%)

USD 21.11B
2823:HK iShares FTSE A50 China

-0.04 (-0.31%)

USD 18.01B
2801:HK iShares Core MSCI China ETF

-0.14 (-0.72%)

USD 17.11B
83188:HK ChinaAMC CSI 300 Index ETF

-0.20 (-0.52%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

-0.01 (-1.05%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

-0.10 (-1.06%)

USD 9.22B
9010:HK iShares Core MSCI AC Asia ex J..

-0.13 (-1.82%)

USD 3.03B
9846:HK iShares Core CSI 300

-0.01 (-0.41%)

USD 2.96B

ETFs Containing 82822:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.75% 73% C 74% C
Dividend Return 3.10% 44% F 28% F
Total Return 20.85% 76% C+ 74% C
Trailing 12 Months  
Capital Gain 17.75% 73% C 73% C
Dividend Return 3.10% 45% F 28% F
Total Return 20.85% 75% C 74% C
Trailing 5 Years  
Capital Gain -13.16% 34% F 71% C-
Dividend Return 11.16% 73% C 36% F
Total Return -2.00% 43% F 69% C-
Average Annual (5 Year Horizon)  
Capital Gain -4.25% 50% F 48% F
Dividend Return -2.05% 57% F 49% F
Total Return 2.20% 67% D+ 44% F
Risk Return Profile  
Volatility (Standard Deviation) 16.54% 59% D- 82% B
Risk Adjusted Return -12.42% 57% F 46% F
Market Capitalization 9.12B 73% C 83% B

Annual Financials (CNY)

Quarterly Financials (CNY)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike